PD-1+ CD8+ T cells in tumor tissues are required for this T-cell immune status, and recently, transcription factor 7 (TCF7)-positive PD-1+ precursor-exhausted CD8+ T cells have been considered important for the therapeutic efficacy of PD-1 blockade (7, 8). The gene discussed is CD8A; the disease is neoplasm.